Echoiq Limited has released a press release.
Amendment to Quarterly Report
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from EchoIQ
- Quarterly Activities/Appendix 4C Cash Flow Report - Dec
- Positive Interim Results From Clinical Trial at St Vincents
- Echo IQ Launches EchoSolv for Immediate Distribution
- Echo IQ Announces Positive Results From US Clinical Study
- Amendment to Appendix 4C
Later from EchoIQ
- Appendix 4D 31 December 2022
- Flagship Clinical Trial Results At St Vincent Hospitals
- Quarterly Activities/Appendix 4C Cash Flow Report
- Echo IQ Expands Commercial Footprint
- HYD: Hydrix signs agreement to sell EIQ's EchoSolv platform
Follow EchoIQ into a list and get an email when it puts out news.
Follow EchoIQ